INVIDA MOVES TOP TALENTS INTO KEY MANAGEMENT ROLES  

Company Builds Senior Management Team; Positions Itself for Growth in Asia Pacific

 

Singapore – March 16, 2011 - Invida Group Pte Ltd, the leading specialty biopharmaceutical company focused on the commercialization of healthcare brands throughout Asia Pacific, is pleased to announce that it has filled two new senior management positions. Invida has appointed Dr. Louis Payet, formerly Regional Director of Business Development and Portfolio Management, to the position of Vice President, Corporate Development and Alliance Management.  Ninia Torres has joined Invida as the Country Manager for Philippines. The appointments are part of Invida’s continuing mission to leverage the wealth of experience in itssenior management team and position the company for exponential growth in Asia Pacific.

 

John A. Graham, Chief Executive Officer of Invida Group, said, "I am pleased to promote Louisto this important strategic role and welcome Ninia to the Invida team to manage one of our most dynamic markets. I look forward to working closely with them. Each brings a specific set of skills that will help us maximize the value of our in-market products and develop new partnerships that capitalize on opportunities in Asia’s rapidly growing markets."

 

Ms. Torres has a rich background of over 20 years in the pharmaceutical industry. She has worked for numerous global pharmaceutical companies including: Warner Lambert, GlaxoSmithKline, Eli Lilly, AstraZeneca and Zuellig Pharma. Her career has been further enriched by key assignments outside the Philippines, including New Zealand, Indonesia, the U.S. and Singapore. Referring to her appointment, Ms. Torres said, “I am looking forward to this new challenge to provide leadership for one of Invida’s largest markets. I want to be an exemplary role model for our employees as we continue to build Invida’s reputation as a trusted Asian partner in the Philipppines. I look forward to working closely with our regional and local partners to achieve our shared goals.”   

 

Tito Tolentino, formerly the President for Invida Philippines, has been retained as Chairman of the Board of Invida Philippines. 

 

Dr. Payet joined Invida in March 2010 and has since implemented a strong framework for sourcing, analysis and negotiation of transactions that has allowed Invida to rationalize itsportfolio while driving growth through strategic acquisitions and investment. As Vice President of Corporate Development and Alliance Management, he will continue to build and maintain this framework through active portfolio and investment reviews, development of good partnering practices and leading pursuits of strategic deals to deliver results for Invida’s shareholders. 

 

Dr. Payet has a diverse background in biotechnology, investment banking, consulting and medical research. He has worked across the Asia-Pacific region for the past 10 years, first as a senior partner with Asia Pacific Bioventures Consulting, and then in the Corporate Finance division of Wilson HTM, one of Australia’s venerable financial services firms. From 2008 until joining Invida in March 2010, Dr. Payet was a senior consultant at Frost & Sullivan, where he managed their Biotechnology and Life Sciences division within the APEC region. 

 

Dr. Louis Payet, Vice President, Corporate Development and Alliance Management, said, "I see this new position as a great opportunity to build partnerships and alliances that help life science and pharmaceutical companies around the world establish a presence in Asia Pacific. The center of gravity of the pharmaceutical sector is moving towards Asia and Invida has the resources and expertise to open up vast new markets to our partners. I look forward to working with them to ensure success.” 

 

About Invida Group Pte Ltd

Invida improves the lives of patients in Asia by commercializing differentiated pharmaceutical products of superior quality - the result of which will allow all Invida stakeholders to prosper. This is done through proven brand marketing and sales know-how, strong expertise across a number of key therapeutic categories and deep experience in all critical Asian markets. Comprehensive functional capabilities provide rapid market access delivered by our passionate team of professionals.

 

With 4,000 employees in 13 markets in Asia Pacific, Invida operates across the commercial value chain from regulatory approval and product launch to lifecycle management. We manage a portfolio of proprietary healthcare brands as well as licensed products from small biotech firms and large multinational companies. Partnering is a critical component of Invida’s business model. We collaborate closely with our partners in developing effective strategies and put our extensive experience behind maximizing the potential of the assets entrusted to us.  For more information on Invida, please see www.invida.com.

 

Media & Investors

LaVoie Group, Inc.

Liz Pingpank

+1 (978) 745-4200 x104

lpingpank@lavoiegroup.com